Literature DB >> 6200213

Characterization of a chemoattractant for endothelium induced by angiogenesis effectors.

K S Raju, G Alessandri, P M Gullino.   

Abstract

The mechanism of neovascularization was further explored by the use of chemically defined angiogenesis effectors. The vascularization of the rabbit cornea was selected as an experimental approach that permits comparison of one cornea treated by the angiogenesis effector with the contralateral cornea of the same subject treated by the same molecule deprived of angiogenic capacity. Under these conditions, we observed that neovascularization was initiated by the appearance of a chemoattractant for the bovine capillary endothelium only in the cornea treated by the angiogenesis effector. The chemoattractant was purified about 150-fold by a single-step procedure, using gelatin:Sepharose affinity chromatography. Chemoattraction resulted from the combined effect of a chemotactic factor(s) and an activating factor(s). The association of the two enhanced 5- to 8-fold the motility of the capillary endothelium in a concentration-dependent manner with optimum at 0.2 mg/ml. The activating factor(s) does not have chemotactic capacity, but without it, chemotaxis is reduced to about one half. The chemotactic complex was present in the cornea regardless of the nature of the angiogenesis effector used as the triggering device. Heat and proteases eliminated chemotaxis and destroyed the chemotactic complex. Thus, neovascularization may be triggered by effectors able to induce in the cornea proteins, normally not present, that influence angiogenesis via mobilization of capillary endothelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200213

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

Review 2.  Gangliosides, copper ions and angiogenic capacity of adult tissues.

Authors:  P M Gullino; M Ziche; G Alessandri
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

3.  The potential of GHK as an anti-aging peptide.

Authors:  Yan Dou; Amanda Lee; Lida Zhu; John Morton; Warren Ladiges
Journal:  Aging Pathobiol Ther       Date:  2020-03-27

4.  Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

Authors:  Gui Young Kwon; Sang Dae Lee; Eon Sub Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

Review 5.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?

Authors:  D Ribatti; B Nico; A Vacca; A Marzullo; N Calvi; L Roncali; F Dammacco
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours.

Authors:  T Oikawa; A Matsuzawa; T Iwaguchi
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

8.  Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

Authors:  D Ribatti; A Vacca; B Nico; F Quondamatteo; R Ria; M Minischetti; A Marzullo; R Herken; L Roncali; F Dammacco
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.

Authors:  Fabio Rinaldi; Anna Trink; Daniela Pinto
Journal:  Dermatol Ther (Heidelb)       Date:  2020-04-11

10.  Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle.

Authors:  D A Schuschke; M W Reed; J T Saari; M D Olson; D M Ackermann; F N Miller
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.